Episode 18: Preventing Tonic-Clonic Seizures in Refractory Epilepsy

Podcast

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with David Vossler, MD.

David Vossler, MD, professor, and medical director, The Neuroscience Institute, UW Medicine Valley Medical Center

David Vossler, MD

Episode 18 of the NeurologyLive Mind Moments podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Episode 18, "Preventing Tonic-Clonic Seizures in Refractory Epilepsy," features an interview with David Vossler, MD, professor, and medical director, The Neuroscience Institute, UW Medicine Valley Medical Center. He discussed the findings of a recently published phase 3 dataset on lacosamide, also known as Vimpat, and its effects on reducing genetic generalized onset tonic-clonic seizures (previously known as primary generalized tonic clonic seizures).

Click here to subscribe to the Mind Moments podcast. Thanks for listening!

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.